captopril (Capoten) reduces the risk of heart attack, stroke, and death in patients with hypertension

August 1998

New evidence now suggests captopril (Capoten) reduces the riskof heart attack, stroke, and death in patients with hypertension.

This is important.

Up until now, only beta-blockers and diuretics have beenshown to reduce cardiovascular morbidity and mortality.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Mississippi pharmacists can get paid for pharmaceutical CARE
Gastroenterology New warnings are coming out for Propulsid (cisapride)
Gastroenterology two 10-day regimens for H. pylori
Antibiotics Amoxil now comes in oral TABLETS
Antibiotics Omnicef (cefdinir), a new oral cephalosporin for children and adults
Antibiotics rifapentine (Priftin) for tuberculosis
Cholesterol new 80 mg Zocor (simvastatin) tablet
Cholesterol garlic doesn't reduce cholesterol
Migraine another "triptan" for migraines...Maxalt (rizatriptan)
Anticoagulants Lovenox (enoxaparin) at HOME
Hypertension new findings are now coming to light regarding drug treatment for hypertension
Hypertension diuretics for the initial treatment of hypertension in the ELDERLY
Hypertension captopril (Capoten) reduces the risk of heart attack, stroke, and death in patients with hypertension
Women's Health Monistat 1, a new one-dose OTC product for vaginal yeast infections
Women's Health new OTC test for urinary infections
Noni Juice, the "cure-all" made from tropical morinda fruit
Neurology & Pain NEW class of pain relievers
Practice Thalidomide (Thalomid) is now approved for leprosy